World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 7 January 2019
Main ID:  ACTRN12618000682246
Date of registration: 26/04/2018
Prospective Registration: No
Primary sponsor: Azienda Ospedaliero Universitaria Maggiore della Carita
Public title: Tidal Volume Challenge During Prone position for Assessing Fluid Responsiveness. A Interventional Prospective Trial
Scientific title: Tidal Volume Challenge During Neurosurgery for Assessing Fluid Responsiveness. A Interventional Prospective Trial of Patients Scheduled for Prone Surgery.
Date of first enrolment: 15/01/2018
Target sample size: 38
Recruitment status: Completed
URL:  https://anzctr.org.au/ACTRN12618000682246.aspx
Study type:  Interventional
Study design:  Purpose: Diagnosis; Allocation: Non-randomised trial; Masking: Open (masking not used);Assignment: Single group;  
Phase: 
Countries of recruitment
Italy
Contacts
Name: Dr Antonio Messina   
Address:  AOU MAGGIORE DELLA CARITA' - INTENSIVE CARE UNIT; Corso Giuseppe Mazzini 18; Novara, Italy, 28100 Italy
Telephone: +3903213733380
Email: mess81rc@gmail.com
Affiliation: 
Name: Dr Antonio Messina   
Address:  AOU MAGGIORE DELLA CARITA' - INTENSIVE CARE UNIT; Corso Giuseppe Mazzini 18; Novara, Italy, 28100 Italy
Telephone: +3903213733380
Email: mess81rc@gmail.com
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Elective neurosurgical prone patients requiring invasive arterial monitoring
Need of fluid challenge as required by the attending anesthetist

Exclusion criteria: The exclusion criteria are 1) any cardiac arrhythmia; 2) reduced left (reduced ejection fraction < 40%) or right (systolic peak velocity of tricuspid annular motion < 0.16 m/s) ventricular ejection fraction; 3) unstable intracranial pressure; 4); Body Mass Index (BMI) > 40; 5) use of vasopressors or inotropes before TVC and EEO applications; 6) chronic lung diseases.

Age minimum: 18 Years
Age maximum: No limit
Gender: Both males and females
Health Condition(s) or Problem(s) studied
Surgery - Other surgery
Anaesthesiology - Other anaesthesiology
Hemodynamic Instability;Hypovolemia;
Hemodynamic Instability
Hypovolemia
Intervention(s)
The TVC has been proposed as novel hemodynamic test to assess fluid responsiveness in ICU patients. TVC consists in the transient increase of Tidal Volume from 6ml/kg to 8ml/kg for 1 minute. The TVC-related changes of stroke volume variation (SVV) and pulse pressure variation (PPV) are highly predictive of fluid responsiveness. The aim of the present study is to assess TVC reliability in a population of neurosurgical patients scheduled for prone or supine surgery.
Brief description of TVC:
1) TVC is a transient increase in the Tidal Volume used to ventilate the patient from 6 to 8 ml/kg of predicted body weight
2) The duration is 1 minute
3) The attending anesthetist will modify the setting of the ventilation in operating room
4) The decision of administer fluids because of transient hypotension (defined as a reduction of >20% of systolic blood pressure recorded at the beginning of the operation) is the indication to perform first the TVC
5) Only the first fluid challenge will be recorded. The frequency of administration will be decided by the attending anesthetist according to the occurrence of hemodynamic instability, for the entire duration of the operation.

The end-expiratory occlusion test is a hemodynamic test aiming to assess fluid responsiveness by means of a interruption of mechanical ventilation. In order to compare TVC with EEO, the EEO will be also performed in all the patients at predefined time points (before and after TVC, when the patient is ventilated with 6ml/kg and 8 lm/kg respectively).
Primary Outcome(s)
Number of participants who are considered 'Responders'; with a responder defined as an increase of at least 10% in stroke volume index measured by means of MOSTCARE system[Immediately following fluid challenge infusion]
Secondary Outcome(s)
Change in pulse pressure measured by means of MOSTCARE system after fluid challenge infusion[after fluid challenge infusion at 10 minutes]
Secondary ID(s)
None
Source(s) of Monetary Support
Azienda Ospedaliero Universitaria Maggiore della Carita
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date:
Contact:
Comitato Etico Interaziendale Novara
Results
Results available: Yes
Date Posted: 12/12/2018
Date Completed: 31/07/2018
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history